| Year |
Citation |
Score |
| 2023 |
Scott-McKean JJ, Jones R, Johnson MW, Mier J, Basten IA, Stasko MR, Costa ACS. Emergence of Treadmill Running Ability and Quantitative Assessment of Gait Dynamics in Young Ts65Dn Mice: A Mouse Model for Down Syndrome. Brain Sciences. 13. PMID 37239215 DOI: 10.3390/brainsci13050743 |
0.326 |
|
| 2021 |
Victorino DB, Pinheiro DJLL, Scott-McKean JJ, Barker S, Stasko MR, Faber J, Scorza CA, Costa ACS. Atypical electrophysiological and behavioral responses to diazepam in a leading mouse model of Down syndrome. Scientific Reports. 11: 9521. PMID 33947925 DOI: 10.1038/s41598-021-89011-y |
0.354 |
|
| 2020 |
Victorino DB, Scott-McKean JJ, Johnson MW, Costa ACS. Quantitative Analysis of Retinal Structure and Function in Two Chromosomally Altered Mouse Models of Down Syndrome. Investigative Ophthalmology & Visual Science. 61: 25. PMID 32416604 DOI: 10.1167/Iovs.61.5.25 |
0.33 |
|
| 2018 |
Scott-McKean JJ, Roque AL, Surewicz K, Johnson MW, Surewicz WK, Costa ACS. Pharmacological Modulation of Three Modalities of CA1 Hippocampal Long-Term Potentiation in the Ts65Dn Mouse Model of Down Syndrome. Neural Plasticity. 2018: 9235796. PMID 29849573 DOI: 10.1155/2018/9235796 |
0.361 |
|
| 2017 |
M Lee Y, Zampieri BL, Scott-McKean JJ, Johnson MW, Costa AC. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome. Stem Cells Translational Medicine. PMID 28371411 DOI: 10.1002/Sctm.16-0128 |
0.305 |
|
| 2013 |
Costa AC, Scott-McKean JJ. Prospects for improving brain function in individuals with Down syndrome. Cns Drugs. 27: 679-702. PMID 23821040 DOI: 10.1007/S40263-013-0089-3 |
0.336 |
|
| 2011 |
Scott-McKean JJ, Costa AC. Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantine. Learning & Memory (Cold Spring Harbor, N.Y.). 18: 774-8. PMID 22101180 DOI: 10.1101/Lm.024182.111 |
0.365 |
|
| 2010 |
Scott-McKean JJ, Chang B, Hurd RE, Nusinowitz S, Schmidt C, Davisson MT, Costa AC. The mouse model of Down syndrome Ts65Dn presents visual deficits as assessed by pattern visual evoked potentials. Investigative Ophthalmology & Visual Science. 51: 3300-8. PMID 20130276 DOI: 10.1167/Iovs.09-4465 |
0.395 |
|
| 2008 |
Scott-McKean JJ, Wenger GR, Tecott LH, Costa AC. 5-HT(1A) Receptor Null Mutant Mice Responding Under a Differential-Reinforcement-of-Low-Rate 72-Second Schedule of Reinforcement. The Open Neuropsychopharmacology Journal. 1: 24-32. PMID 20352018 DOI: 10.2174/1876523800801010024 |
0.352 |
|
| 2008 |
Siddiqui A, Lacroix T, Stasko MR, Scott-McKean JJ, Costa AC, Gardiner KJ. Molecular responses of the Ts65Dn and Ts1Cje mouse models of Down syndrome to MK-801. Genes, Brain, and Behavior. 7: 810-20. PMID 19125866 DOI: 10.1111/J.1601-183X.2008.00428.X |
0.43 |
|
| 2008 |
Costa AC, Scott-McKean JJ, Stasko MR. Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1624-32. PMID 17700645 DOI: 10.1038/Sj.Npp.1301535 |
0.426 |
|
| 2006 |
Stasko MR, Scott-McKean JJ, Costa AC. Hypothermic responses to 8-OH-DPAT in the Ts65Dn mouse model of Down syndrome. Neuroreport. 17: 837-41. PMID 16708025 DOI: 10.1097/01.Wnr.0000220129.78726.Bb |
0.394 |
|
| 2005 |
Costa AC, Stasko MR, Stoffel M, Scott-McKean JJ. G-protein-gated potassium (GIRK) channels containing the GIRK2 subunit are control hubs for pharmacologically induced hypothermic responses. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 7801-4. PMID 16120781 DOI: 10.1523/Jneurosci.1699-05.2005 |
0.316 |
|
| Show low-probability matches. |